Rapt Therapeutics Appoints Peter Svennilson to Board of Directors Portfolio News / By Karina Tin June 18, 2020 Rapt Therapeutics Appoints Peter Svennilson to Board of Directors Read More »
Revolution Medicines Appoints Peter Svennilson to its Board of Directors Portfolio News / By Karina Tin June 18, 2020 Revolution Medicines Appoints Peter Svennilson to its Board of Directors Read More »
Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team Portfolio News / By Karina Tin June 16, 2020 Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team Read More »
Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock Portfolio News / By Karina Tin June 16, 2020 Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock Read More »
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise Portfolio News / By Karina Tin June 12, 2020 Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise Read More »
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 Portfolio News / By Karina Tin June 9, 2020 Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 Read More »
Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration Portfolio News / By Karina Tin June 4, 2020 Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration Read More »
Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock Portfolio News / By Karina Tin May 28, 2020 Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock Read More »
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board Portfolio News / By Karina Tin May 27, 2020 Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board Read More »
Arcus Biosciences and Gilead Sciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies Portfolio News / By Karina Tin May 27, 2020 Arcus Biosciences and Gilead Sciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies Read More »
